PLEKHS1 and thyroid gland undifferentiated (anaplastic) carcinoma: This study was designed to determine PLEKHS1 promoter hotspot mutations in papillary and anaplastic thyroid carcinomas (PTCs and ATCs) and to evaluate if PLEKHS1 expression influences clinical outcome.